Volume 77, Number 23, December 6, 2011
About this course
- Released: 12/05/2011
- Expires: 12/06/2013
Learning Objectives:
Upon completion of the article by Kuhle et al, the participant should be able to:
• Recognize that patients with PML associated with natalizumab treatment may be CSF-JC virus (JCV) PCR-negative in CSF
• Discuss an approach to the diagnosis of CSF-JCV PCR-negative PML in a natalizumab-treated patient
• Discuss the management utilized in this patient with immune reconstitution inflammatory syndrome (IRIS) related to CSF-JCV PCR-negative PML
Core Competencies:
The article by Kuhle et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Yang et al, the participant should be able to:
• Recognize that some commonly used antiepileptic drugs (AEDs) may be associated with severe cutaneous adverse drug reactions (SCARs)
• Briefly discuss the clinical symptomatology characterizing Stevens-Johnson syndrome (SJS), toxic epidermal necrosis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS)
• Discuss the findings from this study from Taiwan regarding the characteristics, outcome, and tolerability toward alternative drugs for AED-induced SCARs
Core Competencies:
The article by Yang et al covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
